Bamlanivmab for Mild-to-Moderate COVID-19

Download Patient Education

Bamlanivmab is an investigational monoclonal antibody therapy for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. It is approved for emergency use by the Food and Drug Administration.

Download PDF: Bamlanivmab for Mild-to-Moderate COVID-19

National Jewish Health authors free downloadable patient education materials to provide you and your family the information and tools to help manage your disease. They include Understanding Booklets, Med Facts, Test Facts, Medication handouts and more.